Titan Spine has announced the company has recently exceeded 1,000 implantations of its Endoskeleton titanium interbody fusion devices featuring Nanoolock surface technology since its launch in the fourth quarter of 2016.
Nanolock is the company’s next-generation surface technology featuring micro and nano-scaled architecture designed to improve the osteogenic response it creates. The products have been used by 74 surgeons in 52 hospitals across 26 US states to date.
